AKAP 79 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AKAP 79 monoclonal antibodies for investigating A-kinase anchoring protein 79 (AKAP 79) in cellular signaling pathways. AKAP 79 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKAP 79 is essential for the spatial and temporal regulation of protein kinase A (PKA) signaling, playing a significant role in processes such as synaptic plasticity and cardiac function. By anchoring PKA to specific cellular compartments, AKAP 79 facilitates the precise modulation of downstream signaling events, which is vital for maintaining cellular homeostasis and responding to external stimuli. Understanding AKAP 79 function can provide insights into various physiological and pathological conditions, including heart disease and neurological disorders. Researchers can explore the molecular mechanisms of AKAP 79 using specific detection methods and advanced visualization techniques. Investigating AKAP 79's interactions with other signaling molecules helps reveal its broader impact on cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of AKAP 79's role in cellular signaling and contribute to potential therapeutic developments.